Management of Neoplasms of the Shoulder



Management of Neoplasms of the Shoulder


Martin M. Malawer

Kristen Kellar-Graney

James C. Wittig




INTRODUCTION

Each bone of the shoulder girdle (Fig. 34-1)—the proximal humerus, the scapula, and the clavicle—can give rise to a primary bone tumor or be involved by an adjacent soft tissue sarcoma.1 The proximal (upper) humerus is one of the most common sites for high-grade malignant bony tumors in both adults and children, and it is the third most common site for osteosarcomas. Chondrosarcomas also commonly involve the shoulder girdle, often arising from the scapula or the proximal humerus. The bones of the shoulder girdle may also be involved secondarily by high-grade soft tissue sarcomas or metastatic tumors that often require resections similar to those used in the treatment of high-grade primary bony sarcomas. Metastatic tumors often involve the shoulder girdle, and because of the extent of bony destruction and the presence of large extraosseous components, the treatment is sometimes similar to that for primary malignant bony sarcomas. For example, hypernephromas (renal cell carcinomas) have a unique propensity to involve the proximal humerus, often as a solitary metastasis. They commonly result in extensive bony destruction with a large soft tissue component.


THREE PHASES OF SURGICAL RESECTION

The surgical treatment of a malignant bony tumor involving the shoulder girdle consists of three stages: (a) wide surgical resection of the tumor, (b) reconstruction of the skeletal defect, and (c) multiple muscle transfers to provide soft tissue coverage, stabilize the shoulder girdle, and restore function to the upper extremity.

The aim is to provide a stable shoulder and preserve a functional elbow and hand. Each of the various surgical techniques currently in use for reconstruction of a segmental defect of the humerus or shoulder girdle offers some degree of stability, function, durability, range of motion (ROM), and preservation of motor power.






FIGURE 34-1. Overall view of shoulder girdle and axillary space.


CLASSIFICATION OF SHOULDER-GIRDLE RESECTIONS

Malawer et al. have developed a six-stage surgical classification system.3 This system is based on current concepts of surgical margins, the relationship of the tumor to anatomic compartments (i.e., intracompartmental vs. extracompartmental), the status of the glenohumeral joint (intra-articular vs. extra-articular), the magnitude of the individual surgical procedures, and the presence or absence of the abductor mechanism (deltoid muscle, rotator cuff muscle, or both).

The six-stage classification is as follows (Fig. 34-2):


Type I: Intra-articular proximal humeral resection

Type II: Partial scapular resection

Type III: Intra-articular total scapulectomy

Type IV: Intra-articular total scapulectomy and humeral head resection (Fig. 34-3B)

Type V: Extra-articular humeral and glenoid resection

Type VI: Extra-articular humeral and total scapular resection

Each of the six types is further modified according to a major variable: the presence or absence of the main motor group, the abductor mechanism (i.e., deltoid and rotator cuff muscles). The abductors are either present (subtype A) or partially or completely resected (subtype B). The abductor mechanism is almost always resected when there is extraosseous extension of a bone tumor in this area. The loss of any component of the
abductor mechanism tends to create a similar functional disability. Regardless of histology or primary bone involvement, subtype A generally entails an intracompartmental resection and subtype B an extracompartmental resection (Table 34-1).






FIGURE 34-2. Surgical classification of shoulder-girdle resections. Shoulder-girdle resections are classified as type I to type VI. In general, types I to III are performed for benign or low-grade tumors of the shoulder girdle, whereas types IV to VI are performed for high-grade malignant tumors. In the schematic key, A denotes abductor muscles retained, whereas B denotes abductor muscles resected. The main abductors of the shoulder girdle include the rotator cuff musculature and the deltoid muscle. In general, these muscles are resected with high-grade tumors but are retained with low-grade tumors. (From Malawer MM, Meller I, Dunham WK. A new surgical classification system for shoulder-girdle resections. Analysis of 38 patients. Clin Orthop 1991;267:33-44.)


TUMOR GROWTH AND ANATOMY

Sarcomas, which arise from mesenchymal tissues (mesodermal embryonic layer), grow in a centripetal manner and form ball-like masses and compress the surrounding muscle into a pseudocapsule layer. Sarcomas typically respect fascial borders and generally grow along the path of least resistance. This growth pattern is in contrast to that of carcinomas, which are invasive and usually penetrate compartmental borders. The pseudocapsule layer contains microscopic, finger-like projections of tumor referred to as satellite nodules. Sarcomas spread locally along the path of least resistance. Surrounding fascial layers resist tumor penetration and provide boundaries to local sarcoma growth. These boundaries form a compartment around the tumor. A sarcoma will grow to fill the compartment in which it arises; only rarely does a sarcoma extend beyond its compartmental boundaries. With reference to bony sarcomas that extend beyond the cortices into the surrounding soft tissues, the term “functional anatomic compartment” refers to the investing muscles that are compressed into a pseudocapsular layer. These muscles provide the fascial borders of the compartment, which has important surgical implications. A wide resection (i.e., compartmental resection) of a bone sarcoma entails removal of the entire tumor and pseudocapsular layer and must therefore encompass the investing normal muscle layers.

The functional compartment surrounding the proximal humerus consists of the deltoid, subscapularis, and remaining rotator cuff musculature, latissimus dorsi, brachialis, and portions of the triceps (Fig. 34-4).

High-grade sarcomas that extend beyond the bony cortices of the proximal humerus involve and compress the investing muscles that form the compartmental borders

and pseudocapsular layer. They grow along the path of least resistance and therefore are directed toward the glenoid and scapular neck by the rotator cuff and the glenohumeral joint capsule. Anteriorly, the tumor is covered by the subscapularis, which bulges into and displaces the neurovascular bundle (axillary vessels and brachial plexus). Only rarely does a proximal humerus sarcoma extend beyond the compartmental borders. In these instances, the tumor usually protrudes through the rotator interval. A wide resection for a high-grade sarcoma must therefore include the surrounding muscles that form the pseudocapsular layer, the axillary nerve, the humeral circumflex vessels, and the glenoid (extra-articular resection).






FIGURE 34-3. (A) Plain radiograph showing the original Tikhoff-Linberg resection. The Tikhoff-Linberg resection was the first shoulder-girdle limb-sparing resection performed and involved the en bloc removal of the scapula, proximal humerus, and distal clavicle. This procedure was initially reported in 1928 and was first performed in Russia. (B) Gross specimen of a Tikhoff-Linberg resection. The scapula, proximal humerus, and clavicle are all covered by the adjacent muscles which are resected en bloc.








TABLE 34-1 Type of Resection, Type of Reconstruction, and Functional Outcomes of 134 Tumors Treated by a Limb-Sparing Resection of the Shoulder Girdle























































































































































Function


Resection Type


n


Proximal Humerus Prosthesis


Scapular Prosthesis


Humeral Head Suspension


Excellent


Good


Moderate


Poor


IA


29


29




20


5


4



IB


7


7




3


3


1



IIA


5





4


1




IIB


12





8


4




IIIA


1




1



1




IIIB


15



3


12


6


3


4


2


IVA


0









IVB


8


4


4



4


2


1


1


VA


1






1




VB


53


53




4


31


11


7


VIA


0









VIB


3



2




1


2



Total


134


92


9


13


49


52


23


10


From Bickels J, Wittig JC, Kollender Y, Kellar-Graney K, Meller I, Malawer MM, Limb-sparing resections of the shoulder girdle. J Am Coll Surg 2002;194(4):422-435.







FIGURE 34-4. Schematic concept of the proximal humerus en bloc resection. The shoulder compartment consists of the proximal one-third of the humerus, the glenohumeral joint, distal clavicle, deltoid, and rotator cuff muscles, as well as the joint capsule. This resection block corresponds to a type V “Malawer Classification” extra-articular resection of the proximal humerus.

Most high-grade scapular sarcomas arise from the region of the scapular neck and body. The compartment consists of all of the muscles that originate on the anterior and posterior surfaces of the scapula. In most cases, the deltoid is protected by the rotator cuff muscles. Because the anatomic origin of most tumors is in the neck, the rotator cuff muscles are compressed into a pseudocapsular layer by sarcomas that arise from the scapula. The subscapularis also protects the neurovascular bundle from tumor involvement. The head of the proximal humerus is contained within the compartment surrounding the scapula. The tumor follows the path of least resistance and typically crosses the glenohumeral joint, grossly or microscopically, to involve the humeral head. Direct tumor extension through joints or articular cartilage is rare and typically occurs as the result of a pathologic fracture. Because of the small size of the glenohumeral joint, the tumor almost always involves the capsule or the synovium. The long head of the biceps tendon, which is intra-articular, is another pathway by which the tumor may cross the joint. Wide resection of a high-grade scapula sarcoma must therefore include the rotator cuff and, in most instances, the humeral head.


INTRA- VERSUS EXTRA-ARTICULAR TUMOR EXTENSION

The shoulder joint appears to be more prone than other joints to intra-articular or pericapsular involvement by high-grade bone sarcomas. Figure 34-5 show the mechanisms of tumor
spread. Direct capsular extension, direct tumor tracking along the long head of the biceps, a poorly planned biopsy, and pathologic fracture are mechanisms of glenohumeral contamination and make intra-articular resection for high-grade sarcomas a higher risk than extra-articular resection for local recurrence. A local recurrence in this region often requires a forequarter amputation and may compromise patient survival. (This is in contrast to most clinical experience with resections of the distal femur, which tend to be intra-articular.) Therefore, extra-articular resection is recommended for most high-grade sarcomas of the proximal humerus and scapula (Fig. 34-6A,B).






FIGURE 34-5. (A) Computed tomography scan of the glenohumeral joint showing destruction of the glenohumeral joint by tumor. The typical mechanism of intra-articular involvement by tumor is via direct extension and by capsular involvement. (B) Magnetic resonance imaging (MRI) scan demonstrating large tumor component adjacent to the proximal humerus with an adjacent skip nodule or enlarged axillary lymph node. MRI scans of the shoulder girdle are essential in evaluation of neoplastic lesions.






FIGURE 34-6. En bloc resection of an osteosarcoma of the proximal humerus. This demonstrates an extra-articular proximal humeral resection (type V). (A) Radiograph of the gross specimen demonstrating the glenohumeral joint and the proximal humerus en bloc, as well as the distal clavicle. (B) Gross specimen of the resection demonstrating the resection with all of the surrounding muscles. Note the glenohumeral joint has been opened following the resection.


CLINICAL EVALUATION


History and Physical Examination

Patients with bone sarcomas typically present to their primary care physician with complaints of a dull, aching pain of several months’ duration. They often seek medical intervention because the pain has become more severe. This increased pain can be correlated with tumor penetration of cortical bone, irritation of the periosteum, or pathologic fracture. Severe night pain in the affected extremity is common. Some patients may describe regional tenderness, difficulty in moving the arm, or a palpable swelling or mass. Physical examination of the extremity usually confirms the presence of a mass or regional swelling and deformity. Children are especially susceptible to referred pain; for this reason, all regional joints should be examined.

The presenting symptoms for a soft tissue sarcoma are different and nonspecific. Typically, the mass presents as a slow-growing, painless lesion. Tumors arising in the upper extremity are more palpable and identified earlier than those in the lower extremity.


Specialist Referral

All patients with suspected malignancies should be referred to an orthopedic oncologist or a cancer center. A multidisciplinary team approach for patients with malignant tumors is essential to providing the best possible clinical outcome. Patients with aggressive benign tumors (i.e., giant cell tumor [GCT], chondroblastoma, or enchondroma) should also be referred.


Unique Anatomic and Surgical Considerations

The local anatomy of a sarcoma determines the extent of the operative procedure required. The following discussion addresses unique considerations of shoulder-girdle anatomy that are relevant to surgery in this area.



  • The glenohumeral joint generally does not serve as an effective barrier to tumor spread. A lesion may cross the joint by direct extension or indirect mechanisms (see Fig. 34-5). It is often necessary to perform an extra-articular resection for high-grade bone sarcomas of the proximal humerus or the scapula (glenoid region).


  • The three major cords of the brachial plexus are in close proximity to the subscapularis muscle, glenohumeral joint, and proximal humerus. Tumors involving the upper scapula, the clavicle, and the proximal humerus often displace the infraclavicular component of the brachial plexus. It may be necessary to sacrifice some of the major nerves if they are encased by neoplasm, or a forequarter amputation may be required.



  • The musculocutaneous and axillary nerves are often in contact with or in close apposition to tumors around the proximal humerus, and before proceeding with resection it is necessary to clearly identify both. It is crucial to preserve the musculocutaneous nerve to preserve a functional elbow. The musculocutaneous nerve generally comes from beneath the coracoid and passes through the conjoint tendon or coracobrachialis muscle within a few centimeters of its origin. The position of this nerve does vary, however, and it may lie within 2 to 8 cm of the coracoid. It then passes through the short head of the biceps and into the long head of the biceps before innervating the brachialis muscle.


  • The axillary nerve is closest to most large tumors of the proximal humerus. It arises from the posterior cord and, along with the circumflex vessels, courses around the subscapularis muscle and the head and neck of the humerus to innervate the deltoid posteriorly. In patients who have large malignant tumors of the proximal humerus, the axillary nerve usually must be resected because of tumor proximity or involvement, and because it is necessary to remove the deltoid muscle and glenoid to provide a satisfactory margin. With large stage IIB bone sarcomas of the proximal humerus, the axillary nerve and deltoid muscles can rarely be preserved. In contrast, the axillary nerve is usually not involved by scapular tumors and therefore can be preserved along with the deltoid muscle. This allows for functional anatomic reconstruction of the scapula with a prosthetic replacement.


  • The brachial artery is surrounded by the three major cords of the brachial plexus and is tethered to the proximal humerus by the anterior and posterior circumflex vessels. A presurgical angiogram is extremely useful to localize the brachial artery and identify the level of the circumflex vessels. Occasionally, one finds anomalous brachial and axillary arteries that would be difficult to identify and explore if not recognized preoperatively. In general, the circumflex vessels are ligated during the initial dissection; this allows the entire axillary artery and the vein and brachial plexus to fall away from the tumor mass. Early ligation of the circumflex vessels is key to the resection of proximal humeral sarcomas.


  • The radial nerve courses along the posterior aspect of the axillary sheath and exits from the posterior cord at the inferior border of the latissimus dorsi muscle. Fortunately, most sarcomas are located in the proximal third of the humerus and do not involve this nerve. However, to avoid injury, the radial nerve must be isolated and protected prior to tumor resection. Sacrifice of the radial nerve is rarely necessary.


PREOPERATIVE EVALUATION AND IMAGING STUDIES

Appropriate imaging studies are crucial to successful resection of tumors of the shoulder girdle (Fig. 34-7). The most useful preoperative evaluations are computed tomography (CT), 3D-CT (Fig. 34-8), magnetic resonance imaging (MRI), arteriography, and three-phase bone scans. For large tumors of the proximal humerus, a venogram may be warranted if there is clinical evidence of distal obstruction.


Computed Tomography

CT is more useful than MRI in determining cortical bone changes, and it is considered complementary to MRI in evaluating the chest wall, clavicle, and axilla. CT is useful for determining the planes of tumor resection. Subtle cortical erosions by adjacent soft tissue sarcomas are better visualized on CT than on MRI. The amount of tumor necrosis can be determined. Often, a reactive rim of calcification can be visualized surrounding tumors that have had a good response to preoperative chemotherapy.


3D Computed Tomography Angiography

3D-CT angiography is a recent technique that has proved to be extremely useful in localizing tumors of the shoulder girdle and visualizing their extensions in three dimensions. By varying the sequence and contrast injection times, the local arteries and veins can be well visualized. This technique has decreased the need for classic angiography. This permits accurate surgical planning for tumors around the shoulder girdle by identifying vascular displacement and may well suggest the surgical plane of dissection. The major drawback of this technique, when compared to classic angiography, is that this technique cannot visualize tumor vascularity (tumor blush), which is well depicted in a classic angiogram (see Fig. 34-8A to D).


Magnetic Resonance Imaging

MRI is used to determine the extent of soft tissue involvement, especially around the glenohumeral joint, along the chest wall, and into the axillary space. It is often difficult to visualize the suprascapular area in patients with large tumors, which may infiltrate below the subscapularis muscle and exit near the coracoid. MRI is especially useful in identifying the extent of intraosseous tumor, which is necessary to determine the length of the resection. Skip metastases can also be identified, although they rarely occur in this area. MRI is not useful for determining the preoperative tumor response to induction chemotherapy. MRI and bone scan studies accurately demonstrate the soft tissue extension as well as the intraosseous extent of the tumor.


Bone Scan

Bone scintigraphy is routinely used to assess the presence of metastatic and polyostotic bone disease as well as involvement of a bone by adjacent soft tissue sarcomas. The appearance of a bone lesion in the flow and pool phases, when assessed by a three-phase bone scan, is useful in determining the biologic activity of the tumor, which may be helpful in determining a diagnosis. Some surgeons utilize the bone scan following induction chemotherapy as an indirect measurement of evaluating tumor response.


Angiography

Angiography is extremely useful and should be done with the arm abducted to determine the relationship of the axillary and brachial vessels to the major tumor, the level of the circumflex vessels, and the presence of any anomalies (Fig. 34-9). The axillary vessels and brachial plexus are often displaced by large tumors in this area. Angiography is also the most reliable means of determining the response to neoadjuvant chemotherapy. The absence of vessels in the tumor or a decrease in tumor vascularity indicates tumor necrosis. If there is a very good angiographic response
(i.e., decrease in or absence of tumor blush), it is indicative of a good response to preoperative chemotherapy. This information is important for determining the extent of surgical margins and also provides prognostic information. For instance, if the tumor has had a good response, it is safe to proceed with a limb-sparing resection. The margins may be narrower with less soft tissue resected. If the tumor has had a poor response, the surgeon may elect to take a wider soft tissue margin or perform an amputation. The venous flow phase is useful to demonstrate venous occlusion or tumor thrombi. If there is any suggestion of occlusion, a brachial venogram should be performed (Fig. 34-10).






FIGURE 34-7. Pigmented villonodular synovitis (PVNS) or aggressive synovitis of the shoulder. (A) This photograph shows an arthroscopic view of the shoulder joint. Note the brownish pigmentation of the synovium. (B) Magnetic resonance imaging scan (T2-weighted fat suppressed) showing a marked distended joint with blood (white area) and bulky synovial disease. (C) Intraoperative photograph showing the proximal humerus following detachment of the pectoralis major muscle. Note the large soft tissue mass surrounding the proximal humerus. (D) Gross specimen following curettage and resection of tumor (PVNS). Note the brownish pigmentation, which is consistent with hemosiderin deposits and marked histiocytic proliferation.


Venography

If venous thrombosis or a mural thrombosis is expected, venography should be performed. The most suspicious finding is extremity edema. Axillary vein thrombosis or occlusion is most common with large shoulder osteosarcomas and chondrosarcomas. (Figs. 34-11 and 34-12) It is indicative of encasement of the vascular structures by neoplasm and therefore indirectly reflects brachial plexus involvement because of the intimacy of the brachial plexus and the axillary vessels. This finding suggests that the tumor is unresectable (Fig. 34-10B).


Biopsy

Because 95% of bone sarcomas have a soft tissue component, a small needle, or core, biopsy is possible (Figs. 34-13 and 34-14). One exception may be the young patient with a suspected round cell tumor from whom more tissue may be required for cytogenetic and immunohistochemical stains.
Another exception would be an older patient in whom a solitary metastatic lesion is suspected and the pathology supports either metastatic carcinoma or a spindle cell sarcoma. This differentiation most often occurs with metastatic renal cell carcinoma. In such a case, a significant amount of tissue may be required to obtain immunohistochemical stains that will differentiate the metastatic tumor from a primary sarcoma.






FIGURE 34-8. Large osteochondroma of the medial aspect of the proximal humerus. (A) CT scan and (B) 3D CT-angiogram demonstrating the osteochondroma and the displacement of the brachial vessels and nerves. (C) Clinical photograph showing the large medial osteochondroma. (D) Intraoperative photograph view showing the displacement of the neurovascular bundle structures corresponding to (A) and (B).


Planning the Biopsy

It is essential to plan and perform the biopsy carefully, because an inappropriate biopsy leading to contamination of the surrounding soft tissues is a common cause of forequarter amputation. In a patient with a tumor of the proximal humerus, a core biopsy through the anterior third of the deltoid muscle is recommended (see Fig. 34-14). Open biopsies are rarely required and may lead to excessive local contamination. If there is a soft tissue component, which occurs 95% of the time, there is no
need to enter the bone. Several samples may be taken from different areas through a single puncture site. Care must be taken to avoid the deltopectoral groove. Contamination of this groove leads to contamination of the pectoralis muscle and, potentially, of the brachial vessels and axillary space (see Fig. 34-13).






FIGURE 34-9. Angiogram of a large scapular sarcoma. Angiograms are essential for evaluation of bulky tumors of the shoulder girdle. This scan demonstrates the relationship of the artery to the tumor and the marked vascularity of most tumors. In general, prior to surgery, vascular tumors are embolized.






FIGURE 34-10. (A) Schematic diagram showing the relationship of the axillary vessels to tumors arising within the axillary space, either from the scapula, proximal humerus, or axillary space itself. The infraclavicular portion of the brachial plexus is often displaced by a tumor mass. The axillary artery and vein can be seen on angiography and axillary venography, respectively. These vessels are both patent but may be compressed. The clinical implication is that there is no nerve involvement and therefore these tumors are usually resectable. (B) Schematic diagram showing an unresectable tumor due to infiltration of the infraclavicular portion of the brachial plexus. An angiogram would still demonstrate a patent artery in this situation, but most importantly, the axillary vein would be occluded and thus the surrounding nerves are infiltrated. Axillary venography has proved to be very important in determining tumor respectability. (From Malawer M, Wittig JC. Resections of the shoulder girdle. In: Malawer MM, Sugarbaker PH, eds. Musculoskeletal Cancer Surgery: Treatment of Sarcomas and Allied Diseases. Dordrecht, Netherlands: Kluwer Academic Publishers; 2001:193.)


Biopsy Technique

The biopsy site is a crucial factor in determining the final operative procedure. For tumors arising within the body of the scapula, a posterior needle biopsy or a biopsy along the axillary border of the scapula is recommended. With lesions involving the scapula and neck, a posterior approach directly through the teres minor is recommended. If an open biopsy is required, a small longitudinal incision in line with the incision that will be used for resection is recommended. Most operative approaches involve an incision along the axillary border of the scapula.

A biopsy of the proximal humerus should be performed through the anterior third of the deltoid, not through the deltopectoral interval. A biopsy through the anterior third of the deltoid results in a limited hematoma that is confined by the deltoid muscle and can be resected with the tumor en bloc (see Fig. 34-13). The axillary nerve innervates the deltoid muscle posteriorly, so the anterior portion of the muscle can be partially resected with minimal loss of function if the remaining deltoid is to be preserved. On the other hand, an open biopsy through the deltopectoral interval will contaminate the pectoralis major muscle and provide a plane for the hematoma to dissect to the chest wall along the brachial vessels. This makes a local resection more difficult and increases the possibility of local recurrence.

Clavicle tumors are biopsied along the length of the clavicle. Unless there is a soft tissue component, a small biopsy is advisable because a needle in this location could injure the brachial plexus and the neurovascular bundle.

Most shoulder-girdle soft tissue sarcomas are easily palpable. Multiple core needle biopsies performed through one puncture site under local anesthesia are recommended. If the mass is not palpable, core biopsies should be performed under fluoroscopic or CT guidance. To obtain multiple specimens
from different areas, the surgeon should reintroduce the needle through the same puncture site, varying the angle. Cultures should be obtained routinely, regardless of the suspected diagnosis, because infection may simulate any malignancy. Touchpreps, frozen sections, or both confirm that lesional tissue has been obtained.






FIGURE 34-11. Axillary venogram. (A) A normal axillary vein going into the innominate vein. (B) Occluded axillary vein which almost always indicates invasion of the brachial plexus and thus unresectability. This is a major indication for a forequarter amputation.






FIGURE 34-12. Following removal of the proximal humerus, the axillary nerve has been preserved. Note the proximity to the brachial vessels. These structures must be initially located and mobilized before the tumor is resected. The local anatomy is often distorted due to a large extraosseous tumor component. (Reprinted with permission from Malawer MM, and Sugarbaker PH, eds. Musculoskeletal Cancer Surgery: Treatment of Sarcomas and Allied Diseases. Kluwer Academic Publishers, 2001.)






FIGURE 34-13. Schematic of the shoulder girdle and the preferred site of a needle or a small incisional biopsy for bony tumors. Biopsy should be performed through the anterior one-third of the deltoid to avoid contamination of the pectoralis major and therefore the brachial vessels underneath. A biopsy should never be performed through the deltopectoral interval. Approximately 95% of bony tumors can be correctly identified with multiple cores obtained through a single puncture site performed under computed tomography guidance. (From Malawer M, Wittig JC. Resections of the shoulder girdle. In: Malawer MM, Sugarbaker PH, eds. Musculoskeletal Cancer Surgery: Treatment of Sarcomas and Allied Diseases. Dordrecht, Netherlands: Kluwer Academic Publishers; 2001:194.)




PAIN CONTROL

A unique method developed for the postoperative management of pain in patients undergoing major tumor surgery is the use of perineural catheters. This technique involves the direct placement of a silastic (epidural type) catheter within the nerve sheath of the brachial plexus prior to closure of the wound (Fig. 34-16). Twenty milliliters of 0.25% of Marcaine is perfused initially, and then a continuous infusion of 2 to 4 mL/hour of 0.025% for the immediate postoperative period is given. This technique reduces the postoperative narcotic requirements by about 90%. This is also a very effective means of controlling phantom limb pain in patients requiring a forequarter amputation.


REHABILITATION AFTER SHOULDER-GIRDLE RESECTION

From a rehabilitation perspective, the outcome of resection is clearly superior to that of a forequarter amputation or shoulder disarticulation. Patients undergoing shoulder-girdle resection retain hand function and good elbow function, but they lose some shoulder function, mainly abduction. Shoulder-girdle resection is less disfiguring than amputation and is associated with only minimal pain and edema. Generally, patients’ acceptance of the outcome of their surgery is good to excellent.

Rehabilitation begins with an orientation program that often features pictures of patients who have undergone the procedure and demonstrations of what one can do postoperatively. Preoperatively, a shoulder mold is fashioned using the involved shoulder, provided its contours are not distorted. The cosmetic shoulder helps preserve the symmetry and appearance of the shoulder contour and can support a bra strap or heavy overcoat.






FIGURE 34-16. Schematic diagram of the perineural catheter utilized for perioperative pain control following most shoulder-girdle resections. At the time of surgery, a small Silastic catheter is placed in the nerve sheath of the brachial plexus. Twenty milliliters of 0.25% bupivacaine is bolused prior to wound closure, and then 4 to 8 mL/hour are infused over the next 48 to 72 hours. This provides excellent pain control for most shoulder-girdle procedures. (From Sugarbaker PH, Bickels J, Malawer M. Above-knee amputation. In: Malawer MM, Sugarbaker PH, eds. Musculoskeletal Cancer Surgery: Treatment of Sarcomas and Allied Diseases. Dordrecht, Netherlands: Kluwer Academic Publishers; 2001:360.)


The patient uses a sling postoperatively, and motion is restricted until the incision is healed. The sutures are removed about 2 weeks after surgery. Edema is controlled with an elasticized glove or elastic stockinette. Active motion of the elbow and hand is initiated to preserve strength and ROM and to help minimize edema.

If the incision heals per primam, assistive elbow motion is started within the confines of the sling as soon as the suction catheters have been removed. At about 2 weeks, the sling is removed for passive shoulder ROM and pronation and supination of the wrist. The patient should continue to use the sling intermittently after the incision is healed, primarily for upright activities in which arm support increases comfort. Once the arm is out of the sling, full ROM of elbow (flexion, extension, pronation, and supination) is performed. Passive ROM to the shoulder (flexion, abduction, and external and internal rotation and pendulum exercise) with the help of a family member or physical therapist is recommended.

Rehabilitation depends on the type of reconstructive technique. In general, patients with endoprosthetic intra-articular allografts or composite allograft reconstruction undergo the same rehabilitation program. Those treated by arthrodesis, allograft, or autograft are immobilized for 4 to 5 weeks to allow early bony union to take place.


TUMORS OF THE PROXIMAL HUMERUS

Despite the complexity of these cases, limb-sparing surgery for both high- and low-grade sarcomas of the proximal humerus is possible in approximately 95% of the cases. Forequarter amputation is indicated mainly for large, fungating tumors, tumors with secondary infections, cases in which there is chest wall involvement, and patients who have had a failed attempt at limb-sparing resection. Preoperative neoadjuvant chemotherapy may allow fracture healing if there is significant tumor necrosis.

Most low-grade sarcomas of the proximal humerus can be treated by type I excision with minimal functional deficit. High-grade sarcomas require a modified Tikhoff-Linberg resection (type V) (see Fig. 34-3). Intra-articular and synovial involvement is more common with high-grade chondrosarcomas and with osteosarcomas of the shoulder girdle than with such tumors at other anatomic sites. Thus, extra-articular, rather than intra-articular, resections are recommended for high-grade tumors of the proximal humerus. Prosthesis, allograft, or allograft prosthetic composite can be used for reconstruction following a marginal resection (type I) for a low-grade lesion. Arthrodesis is rarely performed today. Following resection of a high-grade lesion (stage IIB), the aim is to provide a stable shoulder that will preserve function in the elbow and hand. Regardless of the type of reconstruction planned, the magnitude of the surgical resection depends on the grade of the tumor and its anatomic extent.

A major consideration in the preoperative evaluation and surgical planning is the intraosseous extension of the tumor within the bone marrow. The humerus is shorter than the femur and tibia, the two most common sites of sarcomas, and large tumors of the humerus often require resection of a significantly larger portion of the bone. It is not unusual to resect 50% to 80% of the humerus. Tumors arising within the diaphysis may require a total humeral resection and replacement of the glenohumeral and elbow joints. The surgeon must have various lengths and diameters of intramedullary stems at hand. The final decision about the extent of resection needed is made at the time of surgery.

The abductor mechanism (i.e., the deltoid muscle and the rotator cuff) normally covers the shoulder joint. These structures are usually resected in patients with high-grade proximal humeral sarcomas. Following the resection, joint coverage and stability are essential to eliminate dead space, decrease the risk of infection, and maintain good elbow and hand function. The key muscle transfers in the reconstruction are the pectoralis major, the biceps, and the latissimus dorsi; these must be identified and preserved during the resection.


Specific Tumors of the Proximal Humerus


Benign Tumors


Giant Cell Tumor

GCT is a locally aggressive tumor with a low metastatic potential (Table 34-2). It occurs slightly more often in females than in males. This tumor is thought to arise in the metaphyseal -epiphyseal junction, and large tumors may extend into the metaphysis or, more rarely, the diaphysis. The descriptor “benign” was first applied to GCT to differentiate it from other bony malignancies that required amputation. GCT is now considered a benign aggressive lesion, although 3% to 5% are primarily malignant or will undergo malignant transformation either after radiation therapy or following several local recurrences (Fig. 34-17).

GCTs are eccentric lytic lesions without matrix formation. They have well-defined borders and a sharp transition between the tumor and host bone. Periosteal elevation is rare unless accompanied by a pathologic fracture. The typical GCT comprises two basic cell types. The stroma consists of polygonal to somewhat spindle-shaped cells. Scattered diffusely through the stroma are benign osteoclast-like giant cells. Extensive hemorrhage, fracture, or previous surgery can alter the usual pathologic picture of GCT and make it resemble that of a primary bone sarcoma. Cystic areas with surrounding hemosiderin pigment and xanthoma cells correspond to the grossly observed cyst. Approximately 5% of all GCTs occur around the shoulder girdle.

Treatment of GCT is surgical removal (curettage) along with administration of adjuvant cytotoxic agents such as phenol, zinc chloride, alcohol, hydrogen peroxide, and carbolic acid, or, as the authors prefer, curettage and application of a physical adjuvant such as cryosurgery. Treatment of GCT with curettage, burr drilling, and application of cryosurgery has achieved a local recurrence rate of less than 5% (see section “Cryosurgery”) (Fig. 34-18A to C). Type I resection for GCTs is rarely necessary and is reserved for those tumors in which there is insufficient bone remaining for reconstruction with polymethyl methacrylate (PMMA; cementation). We recommend the treatment of GCT of the proximal humerus with curettage and cryosurgery.


Chondroblastoma (Codman’s Tumor)

Chondroblastoma is a benign aggressive tumor that shows a marked predilection for the epiphysis of the bone. This tumor was originally described by Codman as occurring in the proximal humeral epiphysis (thus named Codman’s tumor). It is composed of round and spindle cells, some of which resemble immature chondrocytes or chondroblasts, hence the name chondroblastoma. Chondroblastomas account for less than 1% of all bone tumors. They are one-fifth as common as GCTs. Most patients are skeletally immature when this tumor occurs: 95% of patients are between 5 and 25 years of age, and most of these tumors occur in teenagers. If a chondroblastoma occurs after skeletal maturity, one must be very suspicious of a clear cell chondrosarcoma. Males are affected twice as often as females. Patients usually present with mild pain that may have been present for several months. About one-third of patients have a joint effusion or fluid in the joint, and swelling and limitation of the joint may occur.









TABLE 34-2 Histogenesis and Anatomic Site of Tumors in 72 Patients Treated by Limb-Sparing Surgery of the Shoulder Girdle




































































































Type of Tumor


Scapula


P. Humerus


Total


Chondrosarcoma


4


13


17


Osteosarcoma


4


24


28


Ewing’s sarcoma


1


1


2


Giant cell tumor


1


0


1


Osteochondroma


2


0


2


Fibrosarcoma


2


0


2


Fibromatosis


3


0


3


Hemangiopericytoma


2


0


2


Synovial sarcoma


0


1


1


Leiomyosarcoma


0


1


1


Malignant fibrous


1


3


4


histiocytoma





Hypernephroma


1


3


4


Hemangiosarcoma


0


1


1


Pleomorphic sarcoma


1


1


2


Paget’s sarcoma


0


1


1


Osteoblastoma


0


1


1


Total


22


50


72


Presented at Surgical Grand Rounds at Georgetown University Medical Center May 2001. Washington DC (unpublished).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 9, 2016 | Posted by in ORTHOPEDIC | Comments Off on Management of Neoplasms of the Shoulder

Full access? Get Clinical Tree

Get Clinical Tree app for offline access